Search Results - "Clough, Courtnee A."

  • Showing 1 - 8 results of 8
Refine Results
  1. 1
  2. 2

    Reprogramming identifies functionally distinct stages of clonal evolution in myelodysplastic syndromes by Hsu, Jasper, Reilly, Andreea, Hayes, Brian J., Clough, Courtnee A., Konnick, Eric Q., Torok-Storb, Beverly, Gulsuner, Suleyman, Wu, David, Becker, Pamela S., Keel, Siobán B., Abkowitz, Janis L., Doulatov, Sergei

    Published in Blood (11-07-2019)
    “…Myeloid neoplasms, including myelodysplastic syndromes (MDS), are genetically heterogeneous disorders driven by clonal acquisition of somatic mutations in…”
    Get full text
    Journal Article
  3. 3

    pEVL: A Linear Plasmid for Generating mRNA IVT Templates With Extended Encoded Poly(A) Sequences by Grier, Alexandra E, Burleigh, Stephen, Sahni, Jaya, Clough, Courtnee A, Cardot, Victoire, Choe, Dongwook C, Krutein, Michelle C, Rawlings, David J, Jensen, Michael C, Scharenberg, Andrew M, Jacoby, Kyle

    Published in Molecular therapy. Nucleic acids (2016)
    “…Increasing demand for large-scale synthesis of in vitro transcribed (IVT) mRNA is being driven by the increasing use of mRNA for transient gene expression in…”
    Get full text
    Journal Article
  4. 4

    ATG4A regulates human erythroid maturation and mitochondrial clearance by Stolla, Massiel Chavez, Reilly, Andreea, Bergantinos, Rochelle, Stewart, Sintra, Thom, Neele, Clough, Courtnee A., Wellington, Rachel C., Stolitenko, Raisa, Abkowitz, Janis L., Doulatov, Sergei

    Published in Blood advances (28-06-2022)
    “…Autophagy is a self-degradation pathway that is essential for erythropoiesis. During erythroid differentiation, autophagy facilitates the degradation of…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Modeling Clonal Progression in SF3B1-Mutant Myelodysplastic Syndrome by Sarchi, Martina, Gallì, Anna, Clough, Courtnee A, Todisco, Gabriele, Creamer, J. Philip, Malcovati, Luca, Doulatov, Sergei

    Published in Blood (23-11-2021)
    “…SF3B1-mutant myelodysplastic syndrome (MDS) has recently been proposed as a distinct disorder characterized by ring sideroblasts, ineffective erythropoiesis…”
    Get full text
    Journal Article
  7. 7

    Mitotic Dysregulation Sensitizes Malignant Stem Cells to CHK1 Inhibition in SF3B1-Mutant Myeloid Neoplasms by Sarchi, Martina, Clough, Courtnee A., Crosse, Edie I., Kim, Jason, Baquero Galvis, Laura D., Gallì, Anna, Creamer, J. Philip, Stewart, Sintra, Pozzi, Sara, Molteni, Elisabetta, Elena, Chiara, Bradley, Robert K., Malcovati, Luca, Doulatov, Sergei

    Published in Blood (02-11-2023)
    “…Myelodysplastic syndromes (MDS) arise from the acquisition of driver mutations in hematopoietic stem cells (HSCs). Splicing factor SF3B1 mutations are…”
    Get full text
    Journal Article
  8. 8

    Dissecting the Role of Aberrant Splicing in Mutant-SF3B1 Myelodysplastic Syndromes by Clough, Courtnee A

    Published 01-01-2022
    “…Mutations in RNA splicing factors are the most recurrent genetic aberrations found in myeloid malignancies, such as myelodysplastic syndromes (MDS). These…”
    Get full text
    Dissertation